Philogen
€22.20Change from previous close: −0.45%Absolute change: −€0.10
At a glance
- Revenue growth
- +324.79%
- 2025 vs 2024
- Net income growth
- +407.10%
- 2025 vs 2024
- Net margin
- 73.1%
- 2024: 61.2%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 437 | 168 | 119 | 126 | — |
| Current assets | 398 | 132 | 89.2 | 99.0 | — |
| Cash and equivalents | 127 | 30.6 | 15.6 | 24.4 | — |
| Short-term investments | 252 | 83.2 | 59.7 | 61.8 | — |
| Inventory | 3.0 | 3.3 | 2.2 | 1.9 | — |
| Net property, plant and equipment | 24.9 | 24.9 | 25.9 | 22.6 | — |
| Other intangible assets | 1.1 | 1.2 | 1.2 | 1.2 | — |
| Current liabilities | 51.3 | 16.6 | 12.7 | 10.8 | — |
| Accounts payable | 13.0 | 9.6 | 7.8 | 6.4 | — |
| Total debt | 10.9 | 11.5 | 12.1 | 11.9 | — |
| Total liabilities | 63.5 | 29.8 | 28.7 | 27.9 | — |
| Total equity (incl. minority) | 374 | 139 | 90.6 | 97.9 | — |
| Retained earnings | 267 | 39.1 | -12.3 | -12.5 | — |
| Minority interest | 0.0 | 0.0 | — | — | — |